Answers are grounded in this paper and cite their sources.
Cardiovascular disease is a significant cause of morbidity and mortality in kidney transplant candidates and recipients. With non-invasive cardiac investigation and coronary revascularisation failing to show consistent benefits in patient outcomes, focus is being placed on medical management of coronary artery disease as a strategy to reduce cardiovascular risk. The joint British Transplantation Society and British Cardiovascular Society guideline on 'Cardiovascular assessment of potential adult kidney transplant recipients' has recently been developed. This manuscript summarises the relevant recommendations from chapters related to medical management of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Asgari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: